Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Surrogate endpoints in randomised controlled trials: a reality check.

× No keyword cloud information.

6 in total

1. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management.

Authors: S Vincent Rajkumar
Journal: Am J Hematol Date: 2022-05-23 Impact factor: 13.265

2. Leaks of Clinical Trial Data and Research Integrity.

Authors: S Vincent Rajkumar; Priya Sampathkumar
Journal: Mayo Clin Proc Date: 2020-07 Impact factor: 7.616

3. Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis.

Authors: Huseyin Naci; Courtney Davis; Jelena Savović; Julian P T Higgins; Jonathan A C Sterne; Bishal Gyawali; Xochitl Romo-Sandoval; Nicola Handley; Christopher M Booth
Journal: BMJ Date: 2019-09-18

4. Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers.

Authors: Virág Réka Szita; Gábor Mikala; András Kozma; János Fábián; Apor Hardi; Hussain Alizadeh; Péter Rajnics; László Rejtő; Tamás Szendrei; László Váróczy; Zsolt Nagy; Árpád Illés; István Vályi-Nagy; Tamás Masszi; Gergely Varga
Journal: Pathol Oncol Res Date: 2022-02-28 Impact factor: 3.201

5. Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.

Authors: Anthony Muchai Manyara; Philippa Davies; Derek Stewart; Christopher J Weir; Amber Young; Nancy J Butcher; Sylwia Bujkiewicz; An-Wen Chan; Gary S Collins; Dalia Dawoud; Martin Offringa; Mario Ouwens; Joseph S Ross; Rod S Taylor; Oriana Ciani
Journal: BMJ Open Date: 2022-10-11 Impact factor: 3.006

Review 6. Multiple myeloma current treatment algorithms.

Authors: S Vincent Rajkumar; Shaji Kumar
Journal: Blood Cancer J Date: 2020-09-28 Impact factor: 11.037

6 in total